Skip to main content

Main menu

  • Home
  • Content
    • Current Issue
    • Ahead of Print
    • Past Issues
    • Supplements
    • Article Type
  • Specialty
    • Articles by Specialty
  • CME/MOC
    • Articles
    • Calendar
  • Info For
    • Manuscript Submission
    • Authors & Reviewers
    • Subscriptions
    • About CCJM
    • Contact Us
    • Media Kit
  • Conversations with Leaders
  • Conference Coverage
    • Kidney Week 2024
    • CHEST 2024
    • ACR Convergence 2023
    • Kidney Week 2023
    • ObesityWeek 2023
    • IDWeek 2023
    • CHEST 2023
    • MDS 2023
    • IAS 2023
    • ACP 2023
    • AAN 2023
    • ACC / WCC 2023
    • AAAAI Meeting 2023
    • ACR Convergence 2022
    • Kidney Week 2022
    • AIDS 2022
  • Other Publications
    • www.clevelandclinic.org

User menu

  • Register
  • Log in

Search

  • Advanced search
Cleveland Clinic Journal of Medicine
  • Other Publications
    • www.clevelandclinic.org
  • Register
  • Log in
Cleveland Clinic Journal of Medicine

Advanced Search

  • Home
  • Content
    • Current Issue
    • Ahead of Print
    • Past Issues
    • Supplements
    • Article Type
  • Specialty
    • Articles by Specialty
  • CME/MOC
    • Articles
    • Calendar
  • Info For
    • Manuscript Submission
    • Authors & Reviewers
    • Subscriptions
    • About CCJM
    • Contact Us
    • Media Kit
  • Conversations with Leaders
  • Conference Coverage
    • Kidney Week 2024
    • CHEST 2024
    • ACR Convergence 2023
    • Kidney Week 2023
    • ObesityWeek 2023
    • IDWeek 2023
    • CHEST 2023
    • MDS 2023
    • IAS 2023
    • ACP 2023
    • AAN 2023
    • ACC / WCC 2023
    • AAAAI Meeting 2023
    • ACR Convergence 2022
    • Kidney Week 2022
    • AIDS 2022

Latest Articles

  • You have access
    Factor V Leiden: How great is the risk of venous thromboembolism?
    Khaldoon Shaheen, MD, M. Chadi Alraies, MD, FACP, Abdul Hamid Alraiyes, MD and Richard Christie, MD
    Cleveland Clinic Journal of Medicine April 2012, 79 (4) 265-272; DOI: https://doi.org/10.3949/ccjm.79a.11072

    The risk of a first episode of thromboembolism is two to five times higher with the heterozygous factor V Leiden mutation, but the absolute risk is still low.

  • You have access
    In Reply: Glucocorticoid-induced diabetes and adrenal suppression (November 2011)
    M. Cecilia Lansang, MD, MPH and Leighanne Kramer Hustak, DNP, BC-FNP, CDE
    Cleveland Clinic Journal of Medicine April 2012, 79 (4) 237-242; DOI: https://doi.org/10.3949/ccjm.79c.04003

    Readers comment on previous articles about glucocorticoid-induced diabetes and adrenal failure (November 2011), essential tremor (December 2011), and Parkinson disease (January 2012).

  • You have access
    Examine before ordering: An algorithm unchanged by new tests
    Brian F. Mandell, MD, PhD
    Cleveland Clinic Journal of Medicine April 2012, 79 (4) 234; DOI: https://doi.org/10.3949/ccjm.79b.12004

    I have always been irked when doctors reflexively order panels of immunologic tests when evaluating patients with “arthritis.”

  • You have access
    Exploring the human genome, and relearning genetics by necessity
    Brian F. Mandell, MD, PhD
    Cleveland Clinic Journal of Medicine March 2012, 79 (3) 162; DOI: https://doi.org/10.3949/ccjm.79b.12003

    The field of medical genetics continues to advance far beyond what many of us were exposed to in medical school.

  • You have access
    In reply: Dabigatran (October 2011)
    Siddharth A. Wartak, MD and John R. Bartholomew, MD
    Cleveland Clinic Journal of Medicine March 2012, 79 (3) 168-169; DOI: https://doi.org/10.3949/ccjm.79c:03005
  • You have access
    Asthma in African Americans: What can we do about the higher rates of disease?
    Stacy K. Silvers, MD and David M. Lang, MD
    Cleveland Clinic Journal of Medicine March 2012, 79 (3) 193-201; DOI: https://doi.org/10.3949/ccjm.79a.11016

    To remedy disparities such as greater disease severity and higher rates of hospitalization and death, we need to ensure that all patients receive proper care and the knowledge they need to control their asthma.

  • You have access
    Dabigatran (October 2011)
    Patricio A. Pazmiño, PhD, MD, FACP, FASN
    Cleveland Clinic Journal of Medicine March 2012, 79 (3) 166; DOI: https://doi.org/10.3949/ccjm.79c:03003

    Readers comment on the oral anticoagulant dabigatran (October 2011), and screening for cervical cancer (November 2011).

  • You have access
    Endoscopic ultrasonography to evaluate pancreatitis
    Siwar Albashir, MD and Tyler Stevens, MD
    Cleveland Clinic Journal of Medicine March 2012, 79 (3) 202-206; DOI: https://doi.org/10.3949/ccjm.79a.11092

    This test has become well accepted in the workup of acute and chronic pancreatitis. Further study is needed in recurrent acute pancreatitis and minimal-change chronic pancreatitis.

  • You have access
    Dabigatran (October 2011)
    Ronald Hirsch, MD
    Cleveland Clinic Journal of Medicine March 2012, 79 (3) 166-168; DOI: https://doi.org/10.3949/ccjm.79c:03004
  • You have access
    In reply: Cervical cancer screening (November 2011)
    Xian Wen Jin, MD, PhD, FACP and Andrea Sikon, MD
    Cleveland Clinic Journal of Medicine March 2012, 79 (3) 164; DOI: https://doi.org/10.3949/ccjm.79c:03002

Pages

  • Previous
  • Next
  • 1
  • …
  • 189
  • 190
  • 191
  • 192
  • 193
  • 194
  • 195
  • 196
  • 197
  • …
  • 798

Navigate

  • Current Issue
  • Past Issues
  • Supplements
  • Article Type
  • Specialty
  • CME/MOC Articles
  • CME/MOC Calendar
  • Media Kit

Authors & Reviewers

  • Manuscript Submission
  • Authors & Reviewers
  • Subscriptions
  • About CCJM
  • Contact Us
  • Cleveland Clinic Center for Continuing Education
  • Consult QD

Share your suggestions!

Copyright © 2025 The Cleveland Clinic Foundation. All rights reserved. The information provided is for educational purposes only. Use of this website is subject to the website terms of use and privacy policy. 

Powered by HighWire